The announcement by the US appliance giant comes at a time when its India business is delivering strong performance. The company reported a 40.13% rise in its consolidated net profit to Rs 53.53 crore ...
Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.
NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback